Assessment of live candidate vaccines for paratuberculosis in animal models and macrophages
- PMID: 20038535
- PMCID: PMC2825941
- DOI: 10.1128/IAI.01020-09
Assessment of live candidate vaccines for paratuberculosis in animal models and macrophages
Abstract
Mycobacterium avium subsp. paratuberculosis (basonym M. paratuberculosis) is the causative agent of paratuberculosis, a chronic enteritis of ruminants. To control the considerable economic effect that paratuberculosis has on the livestock industry, a vaccine that induces protection with minimal side effects is required. We employed transposon mutagenesis and allelic exchange to develop three potential vaccine candidates, which were then tested for virulence with macrophages, mice, and goats. All three models identified the WAg906 mutant as being the most attenuated, but some differences in the levels of attenuation were evident among the models when testing the other strains. In a preliminary mouse vaccine experiment, limited protection was induced by WAg915, as evidenced by a reduced bacterial load in spleens and livers 12 weeks following intraperitoneal challenge with M. paratuberculosis K10. While we found macrophages and murine models to be rapid and cost-effective alternatives for the initial screening of M. paratuberculosis mutants for attenuation, it appears necessary to do the definitive assessment of attenuation with a ruminant model.
Figures




Similar articles
-
A bovine macrophage screening system for identifying attenuated transposon mutants of Mycobacterium avium subsp. paratuberculosis with vaccine potential.J Microbiol Methods. 2009 Apr;77(1):58-62. doi: 10.1016/j.mimet.2009.01.005. Epub 2009 Jan 15. J Microbiol Methods. 2009. PMID: 19386227
-
Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.Vaccine. 2011 Jun 24;29(29-30):4709-19. doi: 10.1016/j.vaccine.2011.04.090. Epub 2011 May 10. Vaccine. 2011. PMID: 21565243 Free PMC article.
-
Immunogenicity and protective efficacy of the Mycobacterium avium subsp. paratuberculosis attenuated mutants against challenge in a mouse model.Vaccine. 2012 Apr 19;30(19):3015-25. doi: 10.1016/j.vaccine.2011.11.029. Epub 2011 Nov 19. Vaccine. 2012. PMID: 22107851
-
A rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis.Front Cell Infect Microbiol. 2014 Sep 9;4:126. doi: 10.3389/fcimb.2014.00126. eCollection 2014. Front Cell Infect Microbiol. 2014. PMID: 25250245 Free PMC article. Review.
-
Vaccination against paratuberculosis.Expert Rev Vaccines. 2008 Aug;7(6):817-32. doi: 10.1586/14760584.7.6.817. Expert Rev Vaccines. 2008. PMID: 18665779 Review.
Cited by
-
Evaluation of eight live attenuated vaccine candidates for protection against challenge with virulent Mycobacterium avium subspecies paratuberculosis in mice.Front Cell Infect Microbiol. 2014 Jul 1;4:88. doi: 10.3389/fcimb.2014.00088. eCollection 2014. Front Cell Infect Microbiol. 2014. PMID: 25072031 Free PMC article.
-
Generation and screening of a comprehensive Mycobacterium avium subsp. paratuberculosis transposon mutant bank.Front Cell Infect Microbiol. 2014 Oct 15;4:144. doi: 10.3389/fcimb.2014.00144. eCollection 2014. Front Cell Infect Microbiol. 2014. PMID: 25360421 Free PMC article.
-
Virulence and immunity orchestrated by the global gene regulator sigL in Mycobacterium avium subsp. paratuberculosis.Infect Immun. 2014 Jul;82(7):3066-75. doi: 10.1128/IAI.00001-14. Epub 2014 May 5. Infect Immun. 2014. PMID: 24799632 Free PMC article.
-
Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine model.Clin Vaccine Immunol. 2013 Apr;20(4):572-81. doi: 10.1128/CVI.00653-12. Epub 2013 Feb 13. Clin Vaccine Immunol. 2013. PMID: 23408524 Free PMC article.
-
Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research.Pathogens. 2020 Aug 6;9(8):641. doi: 10.3390/pathogens9080641. Pathogens. 2020. PMID: 32781698 Free PMC article. Review.
References
-
- Bardarov, S., J. Kriakov, C. Carriere, S. Yu, C. Vaamonde, R. A. McAdam, B. R. Bloom, G. F. Hatfull, and W. R. Jacobs, Jr. 1997. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 94:10961-10966. - PMC - PubMed
-
- Basler, T., R. Geffers, S. Weiss, P. Valentin-Weigand, and R. Goethe. 2008. Mycobacterium avium subspecies induce differential expression of proinflammatory mediators in a murine macrophage model: evidence for enhanced pathogenicity of Mycobacterium avium subspecies paratuberculosis. Immunobiology 213:879-888. - PubMed
-
- Begg, D. J., and J. F. Griffin. 2005. Vaccination of sheep against M. paratuberculosis: immune parameters and protective efficacy. Vaccine 23:4999-5008. - PubMed
-
- Begg, D. J., and R. J. Whittington. 2008. Experimental animal infection models for Johne's disease, an infectious enteropathy caused by Mycobacterium avium subsp. paratuberculosis. Vet. J. 176:129-145. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials